Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification

Eur Heart J. 2024 Feb 16;45(7):535-537. doi: 10.1093/eurheartj/ehad874.

Authors

Stephen Brienesse¹, Rod Passman², Ben Freedman^{3

4}

Affiliations

¹ Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
² Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
³ Heart Research Institute, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.
⁴ Concord Hospital Cardiology and Clinical School, Sydney Medical School, The University of Sydney, Sydney, Australia.

PMID: 38263516
DOI: 10.1093/eurheartj/ehad874

No abstract available

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / surgery
Catheter Ablation*
Humans
Risk Assessment
Treatment Outcome

Substances

Anticoagulants